dihexa hgf/c-met agonist Signaling in Melanocytes and Melanoma dihexa hgf/c-met agonist Molecular mechanism(s)

Statements regarding their efficacy have not been evaluated by the FDA

TB-500 (~5,000 Da) is a Thymosin Beta-4 fragment that regulates actin dynamics and is studied for cardiac, muscle, and dermal repair

b $13,500,000 = ($5 per unit fixed production cost 100,000 units sold) + ($130 per unit variable production cost 100,000 units sold)

Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing

The pairing logic above is mechanistic and based on CagriSema results